In vitro info were being identified that characterize cytochrome P-450 (CYP-450) enzymes as likely considerable contributors to the first metabolism of a number of exogenous cannabinoids, and clinical pharmacogenetic facts further assistance CYP2C9 as a substantial contributor to THC metabolism, and a pharmacokinetic conversation analyze utilizing ketoconazole with oromucosal cannabis https://hemalchem.com/product-category/am-series/